Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -38.68%1.83B | 56.41%12.44B | 65.80%2.98B | -27.84%7.95B | -73.59%1.8B | 0.07%11.02B | 48.74%6.81B | 73.28%11.02B | 44.27%4.58B | -25.95%6.36B |
| Operating income | -38.68%1.83B | 56.41%12.44B | 65.80%2.98B | -27.84%7.95B | -73.59%1.8B | 0.07%11.02B | 48.74%6.81B | 73.28%11.02B | 44.27%4.58B | -25.95%6.36B |
| Cost of sales | 33.99%-1.56B | -122.76%-10.31B | -130.10%-2.36B | 42.52%-4.63B | 81.67%-1.03B | -7.92%-8.05B | -105.00%-5.6B | -79.38%-7.46B | -56.85%-2.73B | 15.25%-4.16B |
| Operating expenses | 33.99%-1.56B | -122.76%-10.31B | -130.10%-2.36B | 42.52%-4.63B | 81.67%-1.03B | -7.92%-8.05B | -105.00%-5.6B | -79.38%-7.46B | -56.85%-2.73B | 15.25%-4.16B |
| Gross profit | -56.51%269.87M | -35.93%2.13B | -19.63%620.52M | 11.95%3.33B | -36.28%772.06M | -16.42%2.97B | -34.41%1.21B | 61.74%3.55B | 28.98%1.85B | -40.23%2.2B |
| Selling expenses | 5.12%-101.62M | -7.29%-233.75M | -13.21%-107.1M | -7.13%-217.86M | 3.89%-94.61M | 28.25%-203.36M | 44.32%-98.43M | -10.89%-283.42M | -78.21%-176.79M | -0.34%-255.59M |
| Administrative expenses | 8.87%-197.55M | 10.89%-358.42M | -0.37%-216.77M | 2.53%-402.2M | -22.63%-215.98M | -23.15%-412.63M | 3.24%-176.13M | 19.01%-335.06M | 3.04%-182.03M | -21.15%-413.69M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 74.29%1.11B | ---- | --637.67M |
| Revaluation surplus | 28.22%-151.07M | -1,665.18%-703.07M | -9,200.27%-210.47M | -1,340.42%-39.83M | -287.33%-2.26M | -97.29%3.21M | -98.84%1.21M | 175.64%118.61M | -40.16%103.94M | -174.61%-156.82M |
| -Changes in the fair value of investment property | 28.22%-151.07M | -1,665.18%-703.07M | -9,200.27%-210.47M | -1,340.42%-39.83M | -287.33%-2.26M | -97.29%3.21M | -98.84%1.21M | 175.64%118.61M | -40.16%103.94M | -174.61%-156.82M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 3.06%-330.19M | -2.39%-719.38M | -5.37%-340.61M | 3.56%-702.6M |
| Special items of operating profit | -228.62%-30.35M | -120.61%-191.68M | 223.78%23.6M | 62.82%-86.89M | -9.01%-19.06M | -203.43%-233.68M | -123.58%-17.49M | 7.03%225.92M | 37.83%74.17M | 19.83%211.09M |
| Operating profit | -291.93%-210.71M | -75.03%643.79M | -75.06%109.78M | 21.40%2.58B | -25.48%440.15M | -42.16%2.12B | -55.46%590.61M | 142.00%3.67B | 26.34%1.33B | -44.58%1.52B |
| Financing cost | -0.81%-284.56M | 20.14%-549.27M | 22.42%-282.27M | -0.71%-687.78M | ---363.85M | ---682.93M | ---- | ---- | ---- | ---- |
| Share of profits of associates | -99.36%609K | 1,754.86%97.98M | 3,094.66%95.86M | 97.82%-5.92M | 97.29%-3.2M | -7,265.56%-271.79M | -2,640.04%-118.04M | -101.09%-3.69M | -584.59%-4.31M | 4,643.45%338.97M |
| Share of profit from joint venture company | 25.41%13.41M | 176.19%22.6M | 167.85%10.69M | -88.89%-29.66M | -438.03%-15.76M | -122.71%-15.7M | 8.95%-2.93M | ---7.05M | ---3.22M | ---- |
| Earning before tax | -629.92%-481.25M | -88.41%215.1M | -214.98%-65.93M | 60.82%1.86B | -87.79%57.34M | -68.49%1.15B | -64.38%469.64M | 97.23%3.66B | 25.52%1.32B | -32.37%1.86B |
| Tax | 33.66%-81.18M | 56.91%-587.93M | 67.84%-122.37M | -60.80%-1.36B | 2.11%-380.52M | 69.28%-848.6M | 65.02%-388.73M | -147.68%-2.76B | -59.81%-1.11B | 26.88%-1.12B |
| After-tax profit from continuing operations | -198.69%-562.43M | -175.98%-372.83M | 41.73%-188.3M | 60.89%490.71M | -499.46%-323.18M | -66.06%305M | -60.96%80.9M | 21.29%898.68M | -41.64%207.22M | -39.25%740.96M |
| Earning after tax | -198.69%-562.43M | -175.98%-372.83M | 41.73%-188.3M | 60.89%490.71M | -499.46%-323.18M | -66.06%305M | -60.96%80.9M | 21.29%898.68M | -41.64%207.22M | -39.25%740.96M |
| Minority profit | -262.47%-70.29M | -979.54%-41.64M | 313.71%43.26M | 96.21%-3.86M | 55.55%-20.24M | -131.20%-101.82M | -129.73%-45.54M | 48.89%326.36M | -24.92%153.2M | -64.61%219.2M |
| Profit attributable to shareholders | -112.53%-492.14M | -166.97%-331.19M | 23.56%-231.56M | 21.57%494.57M | -339.57%-302.94M | -28.92%406.82M | 134.04%126.45M | 9.69%572.33M | -64.23%54.03M | -13.08%521.77M |
| Basic earnings per share | -112.60%-0.1029 | -167.15%-0.0693 | 23.42%-0.0484 | 21.84%0.1032 | -340.30%-0.0632 | -28.88%0.0847 | 134.82%0.0263 | 9.67%0.1191 | -64.33%0.0112 | -12.98%0.1086 |
| Diluted earnings per share | -12.98%0.1086 | |||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.